Proehl Gerald T Insider Trades

Insider Trading History

Track insider trading activity for Proehl Gerald T. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Tenax Therapeutics
Tenax Therapeutics TENX
Director
Holding Value $333k 30,000 shares
Last Trade
Jan 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.9k 3,000 shares
$13.30
$11.09
Dermata Therapeutics
Dermata Therapeutics DRMA
10% owner, President, CEO And Chairman
Holding Value $46.9k 37,500 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$81.8k 37,500 shares
$2.18
$1.25
Dermata Therapeutics- Warrants (13/08/2026)
Dermata Therapeutics- Warrants (13/08/2026) DRMAW
10% owner, President, CEO And Chairman
Holding Value $514 37,500 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$694 37,500 shares
$0.02
$0.01
Dermata Therapeutics
Dermata Therapeutics DRMA
10% owner, President, Chairman, CEO
Holding Value $153k 122,563 shares
Last Trade
Dec 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$250k 122,549 shares
$2.04
$1.25
Dermata Therapeutics- Warrants (13/08/2026)
Dermata Therapeutics- Warrants (13/08/2026) DRMAW
10% owner, President, Chairman, CEO
Holding Value $6.72k 490,496 shares
Last Trade
Dec 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.12k 490,196 shares
$0.02
$0.01
Dermata Therapeutics
Dermata Therapeutics DRMA
10% owner, President, Chairman, CEO
Holding Value $153k 122,549 shares
Last Trade
Dec 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$250k 122,549 shares
$2.04
$1.25
Dermata Therapeutics
Dermata Therapeutics DRMA
10% owner, President, Chairman, CEO
Holding Value $613k 490,496 shares
Last Trade
Dec 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1M 490,196 shares
$2.04
$1.25
Dermata Therapeutics
Dermata Therapeutics DRMA
10% owner, President, Chairman, CEO
Holding Value $98.4k 78,740 shares
Last Trade
Dec 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$161k 78,740 shares
$2.04
$1.25
Dermata Therapeutics
Dermata Therapeutics DRMA
10% owner, President, Chairman, CEO
Holding Value $613k 490,255 shares
Last Trade
Dec 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1M 490,196 shares
$2.04
$1.25
Dermata Therapeutics- Warrants (13/08/2026)
Dermata Therapeutics- Warrants (13/08/2026) DRMAW
10% owner, President, Chairman, CEO
Holding Value $1.68k 122,549 shares
Last Trade
Dec 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.28k 122,549 shares
$0.02
$0.01
Dermata Therapeutics
Dermata Therapeutics DRMA
10% owner, President, Chairman, CEO
Holding Value $153k 122,549 shares
Last Trade
Dec 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$250k 122,549 shares
$2.04
$1.25
Dermata Therapeutics- Warrants (13/08/2026)
Dermata Therapeutics- Warrants (13/08/2026) DRMAW
10% owner, President, Chairman, CEO
Holding Value $6.72k 490,496 shares
Last Trade
Dec 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.12k 490,196 shares
$0.02
$0.01
Dermata Therapeutics- Warrants (13/08/2026)
Dermata Therapeutics- Warrants (13/08/2026) DRMAW
10% owner, President, Chairman, CEO
Holding Value $6.72k 490,255 shares
Last Trade
Dec 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.12k 490,196 shares
$0.02
$0.01
Dermata Therapeutics- Warrants (13/08/2026)
Dermata Therapeutics- Warrants (13/08/2026) DRMAW
10% owner, President, Chairman, CEO
Holding Value $1.68k 122,563 shares
Last Trade
Dec 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.28k 122,549 shares
$0.02
$0.01
Dermata Therapeutics
Dermata Therapeutics DRMA
10% owner, President, Chairman, CEO
Holding Value $613k 490,496 shares
Last Trade
Dec 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1M 490,196 shares
$2.04
$1.25
Dermata Therapeutics- Warrants (13/08/2026)
Dermata Therapeutics- Warrants (13/08/2026) DRMAW
10% owner, President, Chairman, CEO
Holding Value $1.68k 122,549 shares
Last Trade
Dec 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.28k 122,549 shares
$0.02
$0.01
Dermata Therapeutics- Warrants (13/08/2026)
Dermata Therapeutics- Warrants (13/08/2026) DRMAW
10% owner, President, Chairman, CEO
Holding Value $1.08k 78,740 shares
Last Trade
Dec 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.46k 78,740 shares
$0.02
$0.01
Dermata Therapeutics- Warrants (13/08/2026)
Dermata Therapeutics- Warrants (13/08/2026) DRMAW
10% owner, President, Chairman, CEO
Holding Value $0 0 shares
Last Trade
Dec 23, 2025 Purchase (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.46k 78,740 shares
$0.02
$0.01
Dermata Therapeutics
Dermata Therapeutics DRMA
10% owner, President, Chairman, CEO
Holding Value $0 0 shares
Last Trade
Dec 23, 2025 Purchase (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$161k 78,740 shares
$2.04
$1.25
Tenax Therapeutics
Tenax Therapeutics TENX
Director
Holding Value $887k 80,000 shares
Last Trade
Jul 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$460k 80,000 shares
$5.75
$11.09

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up